Prognostic factors for chemotherapy-related toxicity in primary central nervous system lymphoma (PCNSL) treated with high-dose methotrexate (HDMTX) with or without ifosfamide: Results from a German phase III trial (G-PCNSL-SG-1).

• DOI: 10.1200/jco.2011.29.15_suppl.2005
• Publication Date: 2017-02-23T13:58:03Z
• Authors: P. Martus; K. Jahnke; A. Korfel; T. Rose; L. Fischer; R. Moehle; H. A. Klasen; M. Rauch; A. Roeth; B. Hertenstein; T. Fischer; T. Hundsberger; H. Mergenthaler; M. Leithäuser; T. Birnbaum; U. Herrlinger; J. Schubert; J. Birkmann; M. Weller; E. Thiel
• Keywords: 03 medical and health sciences; 0302 clinical medicine; Medizin; 3. Good health

2005 Background: Acute chemotherapy-associated toxicity is an important issue in PCNSL since these patients are usually of advanced age, in impaired clinical condition, and often suffer from comorb...